APO-NAPROXEN / ESOMEPRAZOLE
APOTEX INC
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of APO-NAPROXEN / ESOMEPRAZOLE in Canada?
Yes. APO-NAPROXEN / ESOMEPRAZOLE 375MG 20MG has an active shortage reported to Health Canada (last updated October 9, 2026).
Why is APO-NAPROXEN / ESOMEPRAZOLE not available?
The reason the manufacturer reported: Disruption of the manufacture of the drug.
When will APO-NAPROXEN / ESOMEPRAZOLE be available again?
The manufacturer's estimated resolution date is April 23, 2027. This is an estimate and can change; follow this page to get an email when the status changes.
What this means
Does this mean my pharmacy is out of stock?
Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.
What should I do?
Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.
Estimated Resolution
2027-04-23
~6 months remaining (estimate)
This is the manufacturer's estimated date, not a guarantee — actual resolution may come earlier or later.
DIN
02564521
Strength
375MG 20MG
Dosage Form
TABLET (IMMEDIATE- AND DELAYED-RELEASE)
Route
ORAL
Active Ingredient
NAPROXEN ESOMEPRAZOLE
Tier
Unrated
Last Updated
2026-10-09
Reason for Shortage
Disruption of the manufacture of the drug.
Other Products from APOTEX INC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
50MCG · DIN 02460513
325MG · DIN 02362341
500MG · DIN 02362368
DIN 02290901
325MG · DIN 02362422
500MG · DIN 02362244
10MG · DIN 02240414
20MG · DIN 02296098
150MG · DIN 02296160
75MG · DIN 02230507
2MG · DIN 02554194
2MG · DIN 02554178